CWIAX
Price
$82.59
Change
+$0.54 (+0.66%)
Updated
Jun 2 closing price
Net Assets
151.89B
QDISX
Price
$21.23
Change
+$0.17 (+0.81%)
Updated
Jun 2 closing price
Net Assets
408.01K
Interact to see
Advertisement

CWIAX vs QDISX

Header iconCWIAX vs QDISX Comparison
Open Charts CWIAX vs QDISXBanner chart's image
CWIAX vs QDISX Comparison Chart in %
View a ticker or compare two or three
VS
CWIAX vs. QDISX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIAX is a Buy and QDISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 152B vs. QDISX (408K). QDISX pays higher dividends than CWIAX: QDISX (1.45) vs CWIAX (1.33). CWIAX was incepted earlier than QDISX: CWIAX (24 years) vs QDISX (6 years). CWIAX (0.75) is less costly to investors than QDISX (0.00). CWIAX is a more actively managed with annual turnover of: 44.00 vs. QDISX (25.00). QDISX has a lower initial minimum investment than CWIAX: QDISX (0) vs CWIAX (250). CWIAX annual gain was more profitable for investors over the last year : 22.44 vs. QDISX (21.26). QDISX return over 5 years is better than : 61.80 vs. CWIAX (38.19).
CWIAXQDISXCWIAX / QDISX
Total Expense Ratio0.750.00-
Annual Report Gross Expense Ratio0.750.00-
Fund Existence24 years6 years-
Gain YTD15.65211.252139%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets152B408K37,254,902%
Annual Yield % from dividends1.331.4591%
Returns for 1 year22.4421.26106%
Returns for 3 years54.6561.7389%
Returns for 5 years38.1961.8062%
Returns for 10 years122.63N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSHAX12.600.20
+1.61%
NYLI Cushing® MLP Premier Class A
JCPRX25.76N/A
N/A
JPMorgan US Large Cap Core Plus R5
OIEIX26.19N/A
N/A
JPMorgan Equity Income A
RYBOX65.18N/A
N/A
Rydex Biotechnology A
PSKCX23.33N/A
N/A
Virtus KAR Mid-Cap Growth C